These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6251958)

  • 1. Familial pseudohypoparathyroidism without somatic anomalies.
    Winter JS; Hughes IA
    Can Med Assoc J; 1980 Jul; 123(1):26-31. PubMed ID: 6251958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohypoparathyroidism. Disappearance of the resistance to parathyroid extract during treatment with vitamin D.
    Stögmann W; Fischer JA
    Am J Med; 1975 Jul; 59(1):140-4. PubMed ID: 1138547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism.
    Breslau NA; Notman DD; Canterbury JM; Moses AM
    Am J Med; 1980 Jun; 68(6):856-60. PubMed ID: 6247909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone.
    Metz SA; Baylink DJ; Hughes MR; Haussler MR; Robertson RP
    N Engl J Med; 1977 Nov; 297(20):1084-90. PubMed ID: 198661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone.
    Connors MH; Irias JJ; Golabi M
    Pediatrics; 1977 Sep; 60(3):343-8. PubMed ID: 197477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)].
    Yamada K; Tamura Y; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):983-96. PubMed ID: 190053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudohypoparathyroidism with normal serum calcium level.
    Balachandar V; Pahuja J; Maddaiah VT; Collipp PJ
    Am J Dis Child; 1975 Sep; 129(9):1092-5. PubMed ID: 171942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
    Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE
    J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II.
    Rao DS; Parfitt AM; Kleerekoper M; Pumo BS; Frame B
    J Clin Endocrinol Metab; 1985 Aug; 61(2):285-90. PubMed ID: 2989317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal-nonresponsive, bone-responsive pseudohypoparathyroidism. A case with normal vitamin D metabolite levels and clinical features of rickets.
    Dabbagh S; Chesney RW; Langer LO; DeLuca HF; Gilbert EF; DeWeerd JH
    Am J Dis Child; 1984 Nov; 138(11):1030-3. PubMed ID: 6548601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive Development of PTH Resistance in Patients With Inactivating Mutations on the Maternal Allele of GNAS.
    Usardi A; Mamoune A; Nattes E; Carel JC; Rothenbuhler A; Linglart A
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1844-1850. PubMed ID: 28323910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal pseudohypoparathyroidism.
    Narang M; Salota R; Sachdev SS
    Indian J Pediatr; 2006 Jan; 73(1):97-8. PubMed ID: 16444071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal-resistant hormonoplethoric hypoparathyroidism with evidence for a defective response to cAMP.
    Duck SC; Rosenberg EM; Ratzan SK; Haymond MW
    J Clin Endocrinol Metab; 1978 Sep; 47(3):640-6. PubMed ID: 233678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism.
    Yamamoto M; Takuwa Y; Masuko S; Ogata E
    J Clin Endocrinol Metab; 1988 Mar; 66(3):618-25. PubMed ID: 2832440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
    Knox FG; Preiss J; Kim JK; Dousa TP
    J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of pseudohypoparathyroidism: an informative family study.
    Barr DG; Stirling HF; Darling JA
    Arch Dis Child; 1994 Apr; 70(4):337-8. PubMed ID: 8185370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pseudohypoparathyroidism type I and vitamin D therapy].
    Kovarik J; Weissel M; Neuwirth G; Krepler P; Willvonseder R
    Acta Med Austriaca; 1978; 5(3):106-9. PubMed ID: 222102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.